Mabel Woloj
Impact in
- Endocrinology top 2%
- Escherichia coli research studies
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- Jorge H. Crosa (2 shared papers)Marcelo E. Tolmasky (2 shared papers)Marilyn C. Roberts (2 shared papers)Susana Devoto (5 shared papers)Thomas G. Cleary (5 shared papers)Eduardo López (4 shared papers)Barbara E. Murray (3 shared papers)Larry K. Pickering (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)International Journal of Antimicrobial Agents (2 papers)The Pediatric Infectious Disease Journal (2 papers)Blood (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesArgentinaCanada
In The Last Decade
Mabel Woloj
14 papers receiving 391 citations
Peers
Comparison fields: 5 of 61
- Endocrinology 178
- Molecular Medicine 96
- Microbiology 13
- Infectious Diseases 156
- Hematology 38
Countries citing papers authored by Mabel Woloj
This map shows the geographic impact of Mabel Woloj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Woloj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Woloj more than expected).
Fields of papers citing papers by Mabel Woloj
This network shows the impact of papers produced by Mabel Woloj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Woloj. The network helps show where Mabel Woloj may publish in the future.
Co-authors
The 25 scholars most cited alongside Mabel Woloj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 132 | |
| 2 | 2010 | 57 | |
| 3 | 1986 | 54 | |
| 4 | 1986 | 40 | |
| 5 | 1991 | 29 | |
| 6 | 2014 | 28 | |
| 7 | Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. | 1992 | 24 |
| 8 | 1989 | 13 | |
| 9 | Intussusception associated with Escherichia coli O157:H7. | 1989 | 13 |
| 10 | 1996 | 9 | |
| 11 | 2016 | 6 | |
| 12 | 1995 | 5 | |
| 13 | 1994 | 3 | |
| 14 | 2009 | 2 |
About Mabel Woloj
Mabel Woloj is a scholar working on Molecular Medicine, Epidemiology, Infectious Diseases, Pharmacology and Surgery, having authored 14 papers that have together received 415 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Chronic Lymphocytic Leukemia Research (2 papers), Escherichia coli research studies (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer Treatment and Pharmacology (1 paper), Pleural and Pulmonary Diseases (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Endocrinology (178 citations), Molecular Medicine (96 citations), Microbiology (13 citations), Infectious Diseases (156 citations) and Hematology (38 citations). Mabel Woloj has collaborated with scholars based in United States, Argentina and Canada. Frequent co-authors include Jorge H. Crosa, Marcelo E. Tolmasky, Marilyn C. Roberts, Susana Devoto, Thomas G. Cleary, Eduardo López, Barbara E. Murray, Larry K. Pickering, E. Rubeglio and Mario Dı́az. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, International Journal of Antimicrobial Agents, The Pediatric Infectious Disease Journal, Blood and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.